Wealth Enhancement Advisory Services »

Amneal Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $316k 59k 5.35
2025-12-31 $225k 16k 13.68
2025-09-30 $182k 18k 10.36
2025-06-30 $113k 13k 8.42

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Amneal Pharmaceuticals

BlackRock
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Morgan Stanley
Neuberger Berman Group
Invesco
Nuveen
Allspring Global Investments Holdings
Goldman Sachs Group
Assenagon Asset Management

View all funds holding Amneal Pharmaceuticals